Shineco, Inc. (SISI)
Market Cap | 14.18M |
Revenue (ttm) | 4.09M |
Net Income (ttm) | -7.80M |
Shares Out | 6.45M |
EPS (ttm) | -2.26 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 159,123 |
Open | 2.190 |
Previous Close | 2.240 |
Day's Range | 2.190 - 2.520 |
52-Week Range | 0.611 - 6.930 |
Beta | -0.05 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 15, 2024 |
About SISI
Shineco, Inc., through its subsidiaries, processes and distributes agricultural produce. It also engages in the growing and cultivation of mulberry trees and silkworm cocoons; distribution of fruit business; and processing and distribution of silk and silk fabrics, as well as other by-products. The company was incorporated in 1997 and is headquartered in Beijing, the People's Republic of China. [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/p/9/press14-2499733.jpg)
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today th...
![](https://cdn.snapi.dev/images/v1/g/2/press2-2492758.jpg)
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today t...
![](https://cdn.snapi.dev/images/v1/a/x/press12-2487992.jpg)
Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population
BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that...
![](https://cdn.snapi.dev/images/v1/u/t/press2-2481957.jpg)
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products
Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today tha...
![](https://cdn.snapi.dev/images/v1/l/l/press14-2402034.jpg)
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry
BEIJING , May 1, 2024 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsid...
![](https://cdn.snapi.dev/images/v1/c/z/press17-2275319.jpg)
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the C...
![](https://cdn.snapi.dev/images/v1/k/f/press9-2163215.jpg)
Shineco Announces the Appointment of Two New Executive Officers
BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its B...
![](https://cdn.snapi.dev/images/v1/m/o/press11-2127942.jpg)
Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition
SISI Anticipates the Roll-Out of Additional Restaurants to Develop a Chain of Healthy Food Restaurants BEIJING, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SIS...
![](https://cdn.snapi.dev/images/v1/b/s/press3-2089448.jpg)
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products
![](https://cdn.snapi.dev/images/v1/0/8/press19-1964167.jpg)
Shineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute Test
Registration with the NMPA, China's Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution
![](https://cdn.snapi.dev/images/v1/4/8/press13-1951373.jpg)
Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company
BEIJING, June 28, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that on Ju...
![](https://cdn.snapi.dev/images/v1/b/z/press13-1926429.jpg)
Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce
Association with the Chamber Will Improve Visibility and Could Lead to Potential Collaborations BEIJING, June 08, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a p...
![](https://cdn.snapi.dev/images/v1/9/v/press4-1680386.jpg)
Shineco, Inc. Subsidiary Receives Prior Approval Supplement from the NMPA Jiangsu Bureau for the Marketing Approval of “Cardiac 5-Minute Test”
BEIJING, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/u/o/press8-1666078.jpg)
Shineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling Device
BEIJING, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc.(“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech produ...
![](https://cdn.snapi.dev/images/v1/x/3/press4-1654492.jpg)
Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany
BEIJING, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/5/8/press3-1597378.jpg)
Shineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing Industry
BEIJING, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc.(“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech produ...
![](https://cdn.snapi.dev/images/v1/x/7/press3-1320601.jpg)
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million
BEIJING, April 14, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech pro...
![](https://cdn.snapi.dev/images/v1/g/p/press10-1295498.jpg)
Shineco, Inc. Announces Board and Officer Changes
BEIJING, March 28, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech pro...
![](https://cdn.snapi.dev/images/v1/w/p/press7-1284132.jpg)
Shineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition
BEIJING, March 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech pro...
![](https://cdn.snapi.dev/images/v1/d/b/press18-1274211.jpg)
Shineco, Inc. to Build Its First Tumor Classification Diagnosis and Treatment Center in Weifang City, Shandong Province
BEIJING, March 11, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech pro...
![](https://cdn.snapi.dev/images/v1/u/e/press8-1249040.jpg)
Shineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor Patients
BEIJING, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/j/y/press14-1238671.jpg)
Shineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical Devices
BEIJING, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/x/x/press17-1211371.jpg)
Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant
BEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/h/a/press5-1138407.jpg)
Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD
BEIJING, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...
![](https://cdn.snapi.dev/images/v1/b/8/press8-1135161.jpg)
Shineco, Inc. Intends to Acquire a Controlling Interest of Xiang Peng You Kang (Beijing) Technology Co., Ltd., a Healthcare Services Company
As a Preemptive Action to Develop Comprehensive Medical and Healthcare Services